Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1958 1
1961 1
1978 1
1979 1
1980 1
1981 1
1982 1
1983 5
1984 2
1985 2
1986 1
1990 1
1991 1
1995 1
1996 3
1997 4
1998 2
1999 2
2000 4
2001 6
2002 6
2003 9
2004 12
2005 8
2006 10
2007 12
2008 23
2009 19
2010 18
2011 26
2012 37
2013 39
2014 33
2015 33
2016 25
2017 26
2018 39
2019 34
2020 31
2021 47
2022 47
2023 49
2024 39
2025 36

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

608 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 Study.
Lazzeroni M, Puntoni M, Guerrieri-Gonzaga A, Serrano D, Boni L, Buttiron Webber T, Fava M, Briata IM, Giordano L, Digennaro M, Cortesi L, Falcini F, Serra P, Avino F, Millo F, Cagossi K, Gallerani E, De Simone A, Cariello A, Aprile G, Renne M, Bonanni B, DeCensi A. Lazzeroni M, et al. Among authors: serrano d. J Clin Oncol. 2023 Jun 10;41(17):3116-3121. doi: 10.1200/JCO.22.02900. Epub 2023 Mar 14. J Clin Oncol. 2023. PMID: 36917758 Clinical Trial.
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia.
DeCensi A, Puntoni M, Guerrieri-Gonzaga A, Caviglia S, Avino F, Cortesi L, Taverniti C, Pacquola MG, Falcini F, Gulisano M, Digennaro M, Cariello A, Cagossi K, Pinotti G, Lazzeroni M, Serrano D, Branchi D, Campora S, Petrera M, Buttiron Webber T, Boni L, Bonanni B. DeCensi A, et al. Among authors: serrano d. J Clin Oncol. 2019 Jul 1;37(19):1629-1637. doi: 10.1200/JCO.18.01779. Epub 2019 Apr 11. J Clin Oncol. 2019. PMID: 30973790 Free PMC article. Clinical Trial.
Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation.
Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, Beghini F, Manara S, Karcher N, Pozzi C, Gandini S, Serrano D, Tarallo S, Francavilla A, Gallo G, Trompetto M, Ferrero G, Mizutani S, Shiroma H, Shiba S, Shibata T, Yachida S, Yamada T, Wirbel J, Schrotz-King P, Ulrich CM, Brenner H, Arumugam M, Bork P, Zeller G, Cordero F, Dias-Neto E, Setubal JC, Tett A, Pardini B, Rescigno M, Waldron L, Naccarati A, Segata N. Thomas AM, et al. Among authors: serrano d. Nat Med. 2019 Apr;25(4):667-678. doi: 10.1038/s41591-019-0405-7. Epub 2019 Apr 1. Nat Med. 2019. PMID: 30936548 Free PMC article.
Mental health and drug use in college students: Should we take action?
Pérez T, Pardo MC, Cabellos Y, Peressini M, Ureña-Vacas I, Serrano DR, González-Burgos E. Pérez T, et al. Among authors: serrano dr. J Affect Disord. 2023 Oct 1;338:32-40. doi: 10.1016/j.jad.2023.05.080. Epub 2023 May 27. J Affect Disord. 2023. PMID: 37245551 Free article.
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients.
Bellerba F, Serrano D, Harriet J, Pozzi C, Segata N, NabiNejad A, Piperni E, Gnagnarella P, Macis D, Aristarco V, Accornero CA, Manghi P, Gonzaga AG, Biffi R, Bottiglieri L, Trovato C, Zampino MG, Corso F, Bellocco R, Raimondi S, Rescigno M, Gandini S. Bellerba F, et al. Among authors: serrano d. Neoplasia. 2022 Dec;34:100842. doi: 10.1016/j.neo.2022.100842. Epub 2022 Oct 22. Neoplasia. 2022. PMID: 36279751 Free PMC article. Clinical Trial.
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity.
Anfray C, Mainini F, Digifico E, Maeda A, Sironi M, Erreni M, Anselmo A, Ummarino A, Gandoy S, Expósito F, Redrado M, Serrano D, Calvo A, Martens M, Bravo S, Mantovani A, Allavena P, Andón FT. Anfray C, et al. Among authors: serrano d. J Immunother Cancer. 2021 Sep;9(9):e002408. doi: 10.1136/jitc-2021-002408. J Immunother Cancer. 2021. PMID: 34531246 Free PMC article.
Vitamin D receptor polymorphisms and cancer.
Gandini S, Gnagnarella P, Serrano D, Pasquali E, Raimondi S. Gandini S, et al. Among authors: serrano d. Adv Exp Med Biol. 2014;810:69-105. doi: 10.1007/978-1-4939-0437-2_5. Adv Exp Med Biol. 2014. PMID: 25207361
Antifungal and Antiparasitic Drug Delivery.
Torrado JJ, Serrano DR, Capilla J. Torrado JJ, et al. Among authors: serrano dr. Pharmaceutics. 2020 Apr 4;12(4):324. doi: 10.3390/pharmaceutics12040324. Pharmaceutics. 2020. PMID: 32260348 Free PMC article.
YES1 Is a Druggable Oncogenic Target in SCLC.
Redin E, Garrido-Martin EM, Valencia K, Redrado M, Solorzano JL, Carias R, Echepare M, Exposito F, Serrano D, Ferrer I, Nunez-Buiza A, Garmendia I, García-Pedrero JM, Gurpide A, Paz-Ares L, Politi K, Montuenga LM, Calvo A. Redin E, et al. Among authors: serrano d. J Thorac Oncol. 2022 Dec;17(12):1387-1403. doi: 10.1016/j.jtho.2022.08.002. Epub 2022 Aug 18. J Thorac Oncol. 2022. PMID: 35988891 Free article.
608 results